An Update on the Laboratory Diagnosis of Neuromyelitis Optica Spectrum Disorders

키워드

참고문헌 (64)

1. Mori M, "Worldwide prevalence of neuromyelitis optica spectrum disorders", J Neurol Neurosurg Psychiatry, 89, pp.555~556 (2018)
2. Hor JY, "Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence", Mult Scler Relat Disord, 19, pp.20~24 (2018)
3. Hor JY, "Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide", Front Neurol, 11, pp.501~ (2020)
4. Lennon VA, "A serum autoantibody marker of neuromyelitis optica : distinction from multiple sclerosis", Lancet, 364, pp.2106~2112 (2004)
5. Bukhari W, "Molecular pathogenesis of neuromyelitis optica", Int J Mol Sci, 13, pp.12970~12993 (2012)
6. Kaneko K, "CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS : a cross-sectional study and potential therapeutic implications", J Neurol Neurosurg Psychiatry, 89, pp.927~936 (2018)
7. Ambrosius W, "Myelin oligodendrocyte glycoprotein antibody-associated disease : current insights into the disease pathophysiology, diagnosis and management", Int J Mol Sci, 22, pp.100~ (2021)
8. Menon KK, "Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin", J Neurochem, 69, pp.214~222 (1997)
9. Jégou JF, "C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis", J Immunol, 178, pp.3323~3331 (2007)
10. Kim YJ, "Detection of antiaquaporin-4 antibodies in neuromyelitis optica : comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA", J Clin Lab Anal, 26, pp.184~189 (2012)
11. Isobe N, "Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica", Mult Scler, 18, pp.1541~1551 (2012)
12. Kim W, "Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4", Mult Scler, 18, pp.578~586 (2012)
13. Paul F, "Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica", PLoS Med, 4, pp.e133~ (2007)
14. Jarius S, "Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis", J Neurol Sci, 298, pp.158~162 (2010)
15. Takahashi T, "Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica", Tohoku J Exp Med, 210, pp.307~313 (2006)
16. Jarius S, "Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen", J Neurol Sci, 291, pp.52~56 (2010)
17. De Vidi I, "Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay", Clin Immunol, 138, pp.239~246 (2011)
18. Fazio R, "Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients", Mult Scler, 15, pp.1153~1163 (2009)
19. Ketelslegers IA, "Antibodies against aquaporin-4 in neuromyelitis optica : distinction between recurrent and monophasic patients", Mult Scler, 17, pp.1527~1530 (2011)
20. Prain K, "AQP4 antibody assay sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD", Front Neurol, 10, pp.1028~ (2019)
21. Waters PJ, "Evaluation of aquaporin-4 antibody assays", Clin Exp Neuroimmunol, 5, pp.290~303 (2014)
22. Apiwattanakul M, "Diagnostic utility of NMO", AQP4-IgG in evaluating CNS inflammatory disease in Thai patients, 2012, pp.320, 118~120
23. Long Y, "Neuromyelitis optica immunoglobulin G in Chinese patients detected by immunofluorescence assay on a monkey brain substrate", Neuroimmunomodulation, 19, pp.20~24 (2012)
24. Waters P, "Multicentre comparison of a diagnostic assay : aquaporin-4 antibodies in neuromyelitis optica", J Neurol Neurosurg Psychiatry, 87, pp.1005~1015 (2016)
25. Rogers SW, "Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis", Science, 265, pp.648~651 (2009)
26. Lennon VA, "IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel", J Exp Med, 202, pp.473~477 (2005)
27. Reindl M, "International multicenter examination of MOG antibody assays", Neurol Neuroimmunol Neuroinflamm, 7, pp.e674~ (2020)
28. Mader S, "Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica", PLoS One, 5, pp.e10455~ (2010)
29. 김예슬, "Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria", Journal of Clinical Neurology, 13(2), pp.175~180 (2017), 대한신경과학회[DOI]
30. Kim Y, "Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases", Mult Scler Relat Disord, 40, pp.101939~ (2020)
31. Waters P, "MOG cell-based assay detects non-MS patients with inflammatory neurologic disease", Neurol Neuroimmunol Neuroinflamm, 2, pp.e89~ (2015)
32. Pandit L, "Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost effective cell based assay", J Neuroimmunol, 360, pp.577706~ (2021)
33. Kalluri SR, "Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica", Arch Neurol, 67, pp.1201~1208 (2010)
34. Hayakawa S, "Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay", J Neuroimmunol, 196, pp.181~187 (2008)
35. Fryer JP, "AQP4 autoantibody assay performance in clinical laboratory service", Neurol Neuroimmunol Neuroinflamm, 1, pp.e11~ (2014)
36. Jarius S, "Testing for antibodies to human aquaporin-4 by ELISA : sensitivity, specificity, and direct comparison with immunohistochemistry", J Neurol Sci, 320, pp.32~37 (2012)
37. Waters PJ, "Serologic diagnosis of NMO : a multicenter comparison of aquaporin-4-IgG assays", Neurology, 78, pp.665~671 (2012)
38. Waters PJ, "A multicenter comparison of MOG-IgG cell-based assays", Neurology, 92, pp.e1250~e1255 (2019)
39. Tzartos JS, "Deciphering anti-MOG IgG antibodies : clinical and radiological spectrum, and comparison of antibody detection assays", J Neurol Sci, 410, pp.116673~ (2020)
40. 강은숙, "Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder", Annals of Laboratory Medicine, 32(5), pp.331~338 (2012), 대한진단검사의학회
41. Pisani F, "Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding", J Biol Chem, 286, pp.9216~9224 (2011)
42. Nicchia GP, "Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies", Glia, 57, pp.1363~1373 (2009)
43. Hiroaki Y, "Implications of the aquaporin-4 structure on array formation and cell adhesion", J Mol Biol, 355, pp.628~639 (2006)
44. Crane JM, "Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1", M23 isoforms and orthogonal arrays, 2011, pp.286, 16516~16524
45. Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders", Neurology, 85, pp.177~189 (2015)
46. Jasiak-Zatonska M, "The immunology of neuromyelitis optica—current knowledge, clinical implications, controversies and future perspectives", Int J Mol Sci, 17, pp.273~ (2016)
47. Takahashi T, "Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO : a study on antibody titre", Brain, 130, pp.1235~1243 (2007)
48. Jarius S, "Antibody to aquaporin-4 in the long-term course of neuromyelitis optica", Brain, 131, pp.3072~3080 (2008)
49. Jitprapaikulsan J, "Clinical utility of AQP4-IgG titers and measures of complementmediated cell killing in NMOSD", Neurol Neuroimmunol Neuroinflamm, 7, pp.e727~ (2020)
50. Akaishi T, "Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders(NMOSD)", J Neurol Sci, 410, pp.116671~ (2020)
51. Watanabe M, "Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD", Neurology, 93, pp.e1299~e1311 (2019)
52. Wang J, "Research and progress on biomarkers of neuromyelitis optica spectrum disorders", J Recept Signal Transduct Res, 41, pp.417~424 (2021)
53. Derkus B, "Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy", Biosens Bioelectron, 46, pp.53~60 (2013)
54. Su W, "MicroRNAs mediating CNS inflammation : small regulators with powerful potential", Brain Behav Immun, 52, pp.1~8 (2016)
55. Gómara MJ, "Synthetic peptides for the immunodiagnosis of human diseases", Curr Med Chem, 14, pp.531~546 (2007)
56. Ho JD, "Crystal structure of human aquaporin 4 at 1. 8 A and its mechanism of conductance", Proc Natl Acad Sci U S A, 106, pp.7437~7442 (2009)
57. Owens GP, "Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG", J Biol Chem, 290, pp.12123~12134 (2015)
58. Iorio R, "Astrocytic autoantibody of neuromyelitis optica(NMO-IgG)binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays", J Autoimmun, 40, pp.21~27 (2013)
59. Son M, "Detection of aquaporin-4antibody using aquaporin-4 extracellular loop-based carbon nanotube biosensor for the diagnosis of neuromyelitis optica", Biosens Bioelectron, 78, pp.87~91 (2016)
60. de Souza Moraes A, "A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders", Sci Rep, 9, pp.16136~ (2019)
61. Waters P, "Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis", Arch Neurol, 65, pp.913~919 (2008)
62. McKeon A, "Diagnosis of neuromyelitis spectrum disorders : comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays", Arch Neurol, 66, pp.1134~1138 (2009)
63. status in patients with severe optic neuritis in India, "Int Ophthalmol", 2015, 801~806
64. Yang J, "Accuracy of the fluorescence-activated cell sorting assay for the aquaporin-4antibody(AQP4-Ab) : comparison with the commercial AQP4-Ab assay kit", PLoS One, 11, pp.e0180379~ (2016)

관련 논문AI추천